Several states have adopted "right-to-try" laws allowing terminally ill patients to receive experimental drugs. Is this a good development?
Yes; it may be a patient's last, best option.
Yes; the FDA’s compassionate-use program can take too long.
No; a drug company may not comply with the request, giving the patient false hope.
No; it forces the drug company to take risks in drug development.
No; it can lessen participation in clinical trails.
See this poll on: